Cresco Labs (CRLBF) Total Liabilities (2019 - 2026)

Cresco Labs has reported Total Liabilities for 8 years, with the latest figure at $954.6 million in Q1 2026.

• For the quarter ending Q1 2026, Total Liabilities fell 3.43% year-over-year to $954.6 million; the trailing twelve-month figure through Mar 2026 stood at $954.6 million (down 3.43% YoY), and the FY2025 full-year result was $944.8 million, down 2.31% from the prior year.
• Total Liabilities for Q1 2026 stood at $954.6 million, up from $944.8 million in the prior quarter.
• The five-year high for Total Liabilities was $1.0 billion in Q1 2022, with the low at $917.4 million in Q2 2022.
• Historically, Total Liabilities has averaged $970.2 million across 5 years, with a median of $973.3 million in 2023.
• Annual changes were most pronounced in 2022 — Total Liabilities surged 46.56% — and 2025, when it fell 7.61%.
• Cresco Labs' Total Liabilities stood at $996.0 million in 2022, then slipped by 6.59% to $930.4 million in 2023, then grew by 3.95% to $967.2 million in 2024, then fell by 2.31% to $944.8 million in 2025, then increased by 1.04% to $954.6 million in 2026.
• The last three Total Liabilities figures came in at $954.6 million (Q1 2026), $944.8 million (Q4 2025), and $940.2 million (Q3 2025), per Business Quant data.